Goto-Kakizaki rat is protected from proteinuria after induction of anti-Thy1 nephritis

American Journal of Kidney Diseases

Volumn 39, Issue 5, 2002, Pages 985-1000

  Riley, Stephen George ^a,b   Evans, Rachel Anna ^b,c   Davies, Malcolm ^c   Floege, Jürgen ^c   Phillips, Aled Owain ^c  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^c NONE

Author keywords

Basement membrane; Diabetes; Proteinuria; Proteoglycan (PG)

Indexed keywords

AGRIN; ALPHA ACTIN; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY OX 7; PROTEOGLYCAN; SULFUR 35; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL DAMAGE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOLYSIS; DIABETIC NEPHROPATHY; HISTOPATHOLOGY; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; KIDNEY FUNCTION; MACROPHAGE MIGRATION; MALE; MESANGIUM CELL; NEPHRITIS; NONHUMAN; PATHOPHYSIOLOGY; PROTECTION; PROTEIN EXPRESSION; PROTEINURIA; RAT; RAT STRAIN; TISSUE LEVEL; TISSUE SPECIFICITY; ULTRASTRUCTURE; WESTERN BLOTTING;

EID: 0036240272     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2002.32772     Document Type: Article

References (58)

1. Type II diabetes mellitus: Is the renal risk adequately appreciated?
2. Diabetic nephropathy in type II diabetes
3. Renal proximal tubular cell fibronectin accumulation in response to glucose is polyol pathway dependent
4. Exposure of human renal proximal tubular cells to glucose leads to accumulation of type IV collagen and fibronectin by decreased degradation
5. Elevated D-glucose concentrations modulate TGF-β1 synthesis by human cultured renal proximal tubular cells: The permissive role of platelet derived growth factor
6. Induction of TGF-β1 synthesis in D-glucose primed human proximal tubular cells: Differential stimulation by the macrophage derived pro-inflammatory cytokines IL-1β and TNFα
7. Basic fibroblast growth factor stimulates the release of pre-formed TGF-β1 from human proximal tubular cells in the absence of de-novo gene transcription or mRNA translation
8. Polarity of stimulation and secretion of TGF-β1 by proximal tubular cells
9. Production of spontaneous diabetic rats by repetition of selective breeding
10. Prolonged hyperglycemia is associated with glomerular hypertrophy and renal basement membrane thickening in the Goto-Kakizaki model of NIDDM
11. Augmentation of renal injury by basic fibroblast growth factor of platelet derived growth factor does not induce progressive diabetic nephropathy in the Goto Kakizaki model of NIDDM
12. A clinical-histological study of individuals with diabetes mellitus and proteinuria
13. Glomerulonephritis in diabetic patients and its effect on the prognosis
14. Treatment of experimental mesangioproliferative glomerulonephritis with non-anticoagulant heparin: Therapeutic efficacy and safety
15. Platelets mediate glomerular cell proliferation in immune complex nephritis induced by anti-mesangial cell antibodies in the rat
16. A monoclonal antibody against alpha-smooth muscle actin: A new probe for smooth muscle differentiation
17. Desmin is a specific marker for rhabdomyosarcomas of human and rat origin
18. The heterogeneity of mononuclear phagocytes in lymphoid organs: Distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED 1, ED2 and ED3
19. The cytoskeletal linking proteins, moesin and radixin, are upregulated by platelet derived growth factor, but not basic fibroblast growth factor in experimental mesangial proliferative glomerulonephritis
20. Mechanisms involved in the pathogenesis of tubulointerstitial fibrosis in 5/6-nephrectomized rats
21. CD28-B7 blockade prevents the development of experimental autoimmune glomerulonephritis
22. Renal glomerular proteoglycans; An investigation of their synthesis in vivo using a technique for fixation in situ
23. Improved methods for culturing rat glomerular cells
24. Biosynthesis of hyaluronic acid in cultures of chondrocytes from the Swarm rat chondrosarcoma
25. Glomerular epithelial cell proteoglycans
26. A microassay for analysis of serum sulfate
27. Agrin is a major heparan sulfate proteoglycan in the human glomerular basement membrane
28. Differential expression of agrin in renal basement membranes as revealed by domain-specific antibodies
29. Intensive blood glucose control with sulphonylurease or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes
30. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy
31. Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial
32. Podocyte loss and progressive glomerular injury in type 2 diabetes
33. Cellular events in the evolution of experimental diabetic nephropathy
34. Does extracellular matrix expansion in glomerular disease require mesangial cell proliferation?
35. Structural-functional relationships in diabetic nephropathy
36. Mesangiolysis in diabetic glomeruli: Its role in the formation of nodular lesions
37. Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis
38. Renal injury from angiotensin II mediated hypertension
39. The specificity of nephritogenic antibodies
40. Thy-1.1 in glomeruli of rat kidneys
41. Heparan sulphate proteoglycans of rat embryo fibroblasts. A hydrophobic form may link cytoskeleton and matrix components
42. Distribution of GBM heparan sulfate proteoglycan core protein and side chains in human glomerular diseases
43. Glomerular sieving of high molecular weight proteins in proteinuric rats
44. Glomerular sieving and neutral bovine albumins in proteinuric rats
45. Glomerular heparan sulfate alterations: Mechanisms and relevance for proteinuria
46. The human neutrophil serine proteinases elastase and cathepsin G can mediate glomerular injury in vivo
47. Elastase but not proteinase 3 (PR3) induces proteinuria associated with loss of glomerular basement membrane heparan sulphate after in vivo renal perfusion in rats
48. Acute reversible proteinuria induced by infusion of the polycation hexadimethrine
49. A monoclonal antibody against GBM heparan sulfate induces an acute selective proteinuria in rats
50. Recent insights into the structure and functions of heparan sulfate proteoglycans in the human glomerular basement membrane
51. Glomerular expression of dystroglycans is reduced in minimal change nephrosis but not in focal segmental glomerulosclerosis
52. Alterations in the basement membrane (heparan sulfate) proteoglycan in diabetic mice
53. Effect of diabetes on the glycosaminoglycan component of the human glomerular basement membrane
54. Disturbance in glomerular basement membrane glycosaminoglycans in experimental diabetes
55. Studies on macromolecular components of human glomerular basement membrane and alterations in diabetes
56. Heparan sulfate proteoglycan in the glomerular basement membrane in type 1 diabetes mellitus
57. In vivo effects of hyperglycaemia on the outcome of acute mesangial injury in rats
58. Understanding the nature of renal disease progression